Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.

× No keyword cloud information.

36 in total

1. Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1.

Authors: Thomas D Boyer; Arun J Sanyal; Guadalupe Garcia-Tsao; Frederick Regenstein; Lorenzo Rossaro; Beate Appenrodt; Veit Gülberg; Samuel Sigal; Alice S Bexon; Peter Teuber
Journal: Liver Transpl Date: 2011-11 Impact factor: 5.799

2. New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection.

Authors: Florence Wong; Jacqueline G O'Leary; K Rajender Reddy; Heather Patton; Patrick S Kamath; Michael B Fallon; Guadalupe Garcia-Tsao; Ram M Subramanian; Raza Malik; Benedict Maliakkal; Leroy R Thacker; Jasmohan S Bajaj
Journal: Gastroenterology Date: 2013-08-30 Impact factor: 22.682

Review 3. What's new in the treatment of ascites and spontaneous bacterial peritonitis.

Authors: Andrés Cárdenas; Pere Ginès
Journal: Curr Gastroenterol Rep Date: 2008-02

4. Randomized Controlled Trial Comparing the Efficacy of Terlipressin and Albumin with a Combination of Concurrent Dopamine, Furosemide, and Albumin in Hepatorenal Syndrome.

Authors: Siddharth Srivastava; Sreenivas Vishnubhatla; Shyam Prakash; Hanish Sharma; Bhaskar Thakur; Subrat K Acharya
Journal: J Clin Exp Hepatol Date: 2015-09-01

5. Use of non-selective beta blockers in cirrhosis: the evidence we need before closing (or not) the window.

Authors: Vincenzo La Mura; Giulia Tosetti; Massimo Primignani; Francesco Salerno
Journal: World J Gastroenterol Date: 2015-02-28 Impact factor: 5.742

6. The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study.

Authors: Yoshiyuki Narahara; Hidenori Kanazawa; Choitsu Sakamoto; Hitoshi Maruyama; Osamu Yokosuka; Satoshi Mochida; Masahito Uemura; Hiroshi Fukui; Yasukiyo Sumino; Yasushi Matsuzaki; Naohiko Masaki; Shigehiro Kokubu; Kiwamu Okita
Journal: J Gastroenterol Date: 2011-10-25 Impact factor: 7.527

Review 7. Management of ascites and hepatorenal syndrome.

Authors: Salvatore Piano; Marta Tonon; Paolo Angeli
Journal: Hepatol Int Date: 2017-08-23 Impact factor: 6.047

8. Could serum nitrate and nitrite levels possibly predict hepatorenal syndrome in hepatitis C virus-related liver cirrhosis?

Authors: Waheed Abdelmonsef Mahmoud; Nadia Abdelaaty Abdelkader; Amal Mansor
Journal: Indian J Gastroenterol Date: 2013-11-29

9. Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study.

Authors: Anna Licata; Marcello Maida; Ambra Bonaccorso; Fabio Salvatore Macaluso; Maria Cappello; Antonio Craxì; Piero Luigi Almasio
Journal: World J Hepatol Date: 2013-12-27

10. Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome: A Delphi technique-based consensus.

Authors: Juan P Arab; Juan C Claro; Juan P Arancibia; Jorge Contreras; Fernando Gómez; Cristian Muñoz; Leyla Nazal; Eric Roessler; Rodrigo Wolff; Marco Arrese; Carlos Benítez
Journal: World J Hepatol Date: 2016-09-08